Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether guanfacine represents a tolerable,
potentially effective pharmacotherapy option for cannabis dependence. Interested in seeing
whether guanfacine treatment reduces marijuana consumption, withdrawal symptoms, and craving
as compared to baseline.